Search Results - "Hiroyoshi Yokoi"

Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation by Kario, Kazuomi, Kai, Hisashi, Nanto, Shinsuke, Yokoi, Hiroyoshi

“…Maintaining medication adherence is important in treating hypertension, especially resistant hypertension (RH), and variable medication adherence can confound…”
Get full text

Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome: The PRASFIT-ACS Study by Saito, Shigeru, Isshiki, Takaaki, Kimura, Takeshi, Ogawa, Hisao, Yokoi, Hiroyoshi, Nanto, Shinsuke, Takayama, Morimasa, Kitagawa, Kazuo, Nishikawa, Masakatsu, Miyazaki, Shunichi, Nakamura, Masato

“…Background: Prasugrel is an antiplatelet agent that shows more prompt, potent, and consistent platelet inhibition than clopidogrel. The objective of this study…”
Get full text

Classification and Clinical Impact of Restenosis After Femoropopliteal Stenting by Tosaka, Atsushi, MD, Soga, Yoshimitsu, MD, Iida, Osamu, MD, Ishihara, Takayuki, MD, Hirano, Keisuke, MD, Suzuki, Kenji, MD, Yokoi, Hiroyoshi, MD, Nanto, Shinsuke, MD, Nobuyoshi, Masakiyo, MD

“…Objectives The purpose of this study was to investigate the relationship between angiographic patterns of in-stent restenosis (ISR) after femoropopliteal (FP)…”
Get full text

Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan　― Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease by Ishii, Hideki, Amano, Tetsuya, Yamaji, Kyohei, Kohsaka, Shun, Yokoi, Hiroyoshi, Ikari, Yuji

“…Background:With the rapid spread of COVID-19, hospitals providing percutaneous coronary intervention (PCI) were placed in unique and unfamiliar circumstances…”
Get full text

Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions by Ohki, Takao, MD, PhD, Kichikawa, Kimihiko, MD, Yokoi, Hiroyoshi, MD, Uematsu, Masaaki, MD, PhD, Yamaoka, Terutoshi, MD, PhD, Maeda, Koji, MD, Kanaoka, Yuji, MD, PhD

“…Abstract Objective The objective of this study was to assess 1-year safety, efficacy, and invasiveness outcomes of endovascular stent grafting of symptomatic…”
Get full text

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI by Davies, Justin E, Sen, Sayan, Dehbi, Hakim-Moulay, Al-Lamee, Rasha, Petraco, Ricardo, Nijjer, Sukhjinder S, Bhindi, Ravinay, Lehman, Sam J, Walters, Darren, Sapontis, James, Janssens, Luc, Vrints, Christiaan J, Khashaba, Ahmed, Laine, Mika, Van Belle, Eric, Krackhardt, Florian, Bojara, Waldemar, Going, Olaf, Härle, Tobias, Indolfi, Ciro, Niccoli, Giampaolo, Ribichini, Flavo, Tanaka, Nobuhiro, Yokoi, Hiroyoshi, Takashima, Hiroaki, Kikuta, Yuetsu, Erglis, Andrejs, Vinhas, Hugo, Canas Silva, Pedro, Baptista, Sérgio B, Alghamdi, Ali, Hellig, Farrel, Koo, Bon-Kwon, Nam, Chang-Wook, Shin, Eun-Seok, Doh, Joon-Hyung, Brugaletta, Salvatore, Alegria-Barrero, Eduardo, Meuwissen, Martijin, Piek, Jan J, van Royen, Niels, Sezer, Murat, Di Mario, Carlo, Gerber, Robert T, Malik, Iqbal S, Sharp, Andrew S.P, Talwar, Suneel, Tang, Kare, Samady, Habib, Altman, John, Seto, Arnold H, Singh, Jasvindar, Jeremias, Allen, Matsuo, Hitoshi, Kharbanda, Rajesh K, Patel, Manesh R, Serruys, Patrick, Escaned, Javier

“…In this trial involving 2492 patients, coronary revascularization guided by iFR, as compared with fractional flow reserve-guided revascularization, was within…”
Get full text

Health economics-based verification of functional myocardial ischemia evaluation of stable coronary artery disease in Japan: A long-term longitudinal study using propensity score matching by Takura, Tomoyuki, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, Matsumoto, Naoya, Yoshida, Eri, Nakata, Tomoaki

“…The procedural numbers and medical costs of percutaneous coronary intervention (PCI), mainly elective PCI, have been increasing in Japan. Owing to increased…”
Get full text

Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics by Sakakura, Kenichi, Ito, Yoshiaki, Shibata, Yoshisato, Okamura, Atsunori, Kashima, Yoshifumi, Nakamura, Shigeru, Hamazaki, Yuji, Ako, Junya, Yokoi, Hiroyoshi, Kobayashi, Yoshio, Ikari, Yuji

“…Rotational atherectomy (RA) has been widely used for percutaneous coronary intervention (PCI) to severely calcified lesions. As compared to other countries, RA…”
Get full text

Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery by Ohki, Takao, Kichikawa, Kimihiko, Yokoi, Hiroyoshi, Iida, Osamu, Yamaoka, Terutoshi, Maeda, Koji, Kanaoka, Yuji

“…We assessed the long-term safety and efficacy of endovascular stent grafting to treat long, complex lesions in the superficial femoral artery (SFA). The…”
Get full text

Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial by Iida, Osamu, Soga, Yoshimitsu, Urasawa, Kazushi, Saito, Shigeru, Jaff, Michael R., Wang, Hong, Ookubo, Hiroko, Yokoi, Hiroyoshi

“…Purpose: To assess the safety and effectiveness of the MDT-2113 (IN.PACT Admiral) drug-coated balloon (DCB) for the treatment of de novo and native artery…”
Get full text

Consensus Statement on Renal Denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS) by Kario, Kazuomi, Kai, Hisashi, Rakugi, Hiromi, Hoshide, Satoshi, Node, Koichi, Maekawa, Yuichiro, Tsutsui, Hiroyuki, Sakata, Yasushi, Aoki, Jiro, Nanto, Shinsuke, Yokoi, Hiroyoshi

“…This is the first consensus statement of the Joint Committee on Renal Denervation of the Japanese Society of Hypertension (JSH)/Japanese Association of…”
Get full text

An Individual-Level Meta-Analysis Using Real-World and Pivotal Studies on Mortality From the Use of Paclitaxel-Containing Devices in Japanese Femoropopliteal Disease Patients by Nakamura, Masato, Takata, Munenori, Yokoi, Hiroyoshi, Ueno, Takafumi, Suzuki, Yuka, Ikeda, Koji, Yamaguchi, Takuhiro

“…Background:The effect of treatment with paclitaxel-containing devices (PTXD) on mortality in patients with peripheral artery disease remains…”
Get full text

Venous Stenting for Postthrombotic Iliocaval Venous Obstructive Disease: Clinical Efficacy and Mid-term Outcomes by Hoshino, Yuji, Yokoi, Hiroyoshi

“…Postthrombotic syndrome (PTS) can cause both venous outflow obstruction and deep venous reflux, and results in severe symptoms of chronic venous disease…”
Get full text

Real-World Clinical Outcomes of IN.PACT Admiral Drug-Coated Balloon for Femoropopliteal Artery Disease　― 12-Month Results From Japan Post-Market Surveillance Study by Soga, Yoshimitsu, Iida, Osamu, Fujihara, Masahiko, Kawasaki, Daizo, Saito, Shigeru, Urasawa, Kazushi, Yokoi, Hiroyoshi, Fernandez, Eric J., Guo, Jia, Nakamura, Masato, on behalf of the IN.PACT Japan Post-Market Surveillance Study

“…Background:To confirm the safety and efficacy of the IN.PACT Admiral drug-coated balloon (DCB) based on the indication approved by the Pharmaceuticals and…”
Get full text

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial by Kario, Kazuomi, Yokoi, Yoshiaki, Okamura, Keisuke, Fujihara, Masahiko, Ogoyama, Yukako, Yamamoto, Eiichiro, Urata, Hidenori, Cho, Jin-Man, Kim, Chong-Jin, Choi, Seung-Hyuk, Shinohara, Keisuke, Mukai, Yasushi, Ikemoto, Tomokazu, Nakamura, Masato, Seki, Shuichi, Matoba, Satoaki, Shibata, Yoshisato, Sugawara, Shigeo, Yumoto, Kazuhiko, Tamura, Kouichi, Yoshihara, Fumiki, Nakamura, Satoko, Kang, Woong Chol, Shibasaki, Taro, Dote, Keigo, Yokoi, Hiroyoshi, Matsuo, Akiko, Fujita, Hiroshi, Takahashi, Toshiyuki, Kang, Hyun-Jae, Sakata, Yasushi, Horie, Kazunori, Inoue, Naoto, Sasaki, Ken-Ichiro, Ueno, Takafumi, Tomita, Hirofumi, Morino, Yoshihiro, Nojima, Yuhei, Kim, Chan Joon, Matsumoto, Tomoaki, Kai, Hisashi, Nanto, Shinsuke

“…Renal denervation is a promising new non-pharmacological treatment for resistant hypertension. However, there is a lack of data from Asian patients. The…”
Get full text

Early P2Y12 Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting　― PENDULUM Mono 24-Month Analysis by Nakagawa, Yoshihisa, Kadota, Kazushige, Nakao, Koichi, Shite, Junya, Yokoi, Hiroyoshi, Kozuma, Ken, Tanabe, Kengo, Akasaka, Takashi, Shinke, Toshiro, Ueno, Takafumi, Hirayama, Atsushi, Uemura, Shiro, Iijima, Raisuke, Harada, Atsushi, Kuroda, Takeshi, Takita, Atsushi, Murakami, Yoshitaka, Saito, Shigeru, Nakamura, Masato

“…Background: In PENDULUM mono, Japanese patients with high bleeding risk (HBR) received short-term dual antiplatelet therapy (DAPT) followed by single…”
Get full text

Clinical Outcomes After Percutaneous Coronary Intervention in East Asian Patients　― 30-Month Results of the PENDULUM Registry by Kadota, Kazushige, Nakao, Koichi, Nakagawa, Yoshihisa, Shite, Junya, Yokoi, Hiroyoshi, Kozuma, Ken, Tanabe, Kengo, Akasaka, Takashi, Shinke, Toshiro, Ueno, Takafumi, Hirayama, Atsushi, Uemura, Shiro, Harada, Atsushi, Kuroda, Takeshi, Takita, Atsushi, Iijima, Raisuke, Murakami, Yoshitaka, Saito, Shigeru, Nakamura, Masato

“…Background: The 12-month results of the PENDULUM registry showed that after implantation of second-generation drug-eluting stents (DES), high P2Y12reaction…”
Get full text

Drug‐coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2‐year results of the MDT‐2113 SFA Japan randomized trial by Iida, Osamu, Soga, Yoshimitsu, Urasawa, Kazushi, Saito, Shigeru, Jaff, Michael R., Wang, Hong, Ookubo, Hiroko, Yokoi, Hiroyoshi

“…Objectives To assess the longer‐term safety and efficacy of the IN.PACT Admiral (MDT‐2113) drug‐coated balloon (DCB) for the treatment of de novo and…”
Get full text

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry by Nakamura, Masato, Kadota, Kazushige, Nakao, Koichi, Nakagawa, Yoshihisa, Shite, Junya, Yokoi, Hiroyoshi, Kozuma, Ken, Tanabe, Kengo, Iijima, Raisuke, Harada, Atsushi, Kuroda, Takeshi, Murakami, Yoshitaka

“…We aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary…”
Get full text

Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: a retrospective cohort study using a medical information database from Japanese hospitals by Yokoi, Hiroyoshi, Oda, Eisei, Kaneko, Kazuki, Matsubayashi, Kenta

“…In this real-world, retrospective cohort study of 9753 patients in Japan prescribed dual antiplatelet therapy (DAPT) following percutaneous coronary…”
Get full text